866-997-4948(US-Canada Toll Free)

Tesetaxel (Gastric Cancer) Analysis and Forecasts to 2020

Published By :

GlobalData

Published Date : Oct 2011

Category :

Cancer

No. of Pages : 21 Pages


GlobalDatas pharmaceuticals report, Tesetaxel (Gastric Cancer) Analysis and Forecasts to 2020 provides Tesetaxel sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Gastric Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Scope

  • Therapy area profile including patient population for the seven major markets
  • Analysis and review of Tesetaxel including sales data
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Tesetaxel including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Detailed sales forecast for 2014-2020 for Tesetaxel in the US, EU5 and Japan.

Reasons to buy

  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance 
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of Contents

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Introduction 4
2.1 Gastric Cancer Market 4
2.2 Gastric Cancer Disease 4
2.3 GlobalData Pipeline Report Guidance 6

3 Gastric Cancer Disease: Market Characterization 7
3.1 Gastric Cancer Disease Market 7
3.2 Gastric Cancer Disease Market Forecasts and CAGR 7
3.3 Drivers for the Gastric Cancer Disease Market 8
3.3.1 High Prevalence 8
3.3.2 High Incidence 8
3.3.3 Low Initial Diagnosis Rate 9
3.3.4 High Mortality Rate 9

4 Tumor Node Metastases (TNM) Classification of gastric cancer 10

5 Tesetaxel 13

5.1 Introduction 13
5.2 Mechanism of Action 13
5.3 Clinical Studies 13
5.4 Orphan Drug Status 14
5.5 Fast Track Designation 14
5.6 Sales drivers 14
5.6.1 Gastric Cancer Market 14
5.6.2 Unmet Medical Need 14
5.6.3 Potential Benefits 14
5.6.4 Oral Administration 14
5.6.5 Affordable Pricing 15
5.7 Drug Risk Benefit Score 15
5.7.1 Efficacy 15
5.7.2 Safety 15
5.7.3 Compliance 15
5.7.4 Dosing Convenience 16
5.8 Intensity of Competition 16
5.9 Sales forecast 16
5.9.1 Target patient Pool of Tesetaxel 16
5.9.2 Dosing 17
5.9.3 Market Penetration 17
5.9.4 Annual Cost of Therapy 18
5.9.5 Sales Projections of Tesetaxel 18

6 Gastric Cancer Market: Appendix 19
6.1 Market Definitions 19
6.2 List of Abberiviations 19
6.3 Research Methodology 19
6.3.1 Coverage 19
6.3.2 Secondary Research 19
6.3.3 Forecasting 20
6.3.4 Number of Patients Approved to take the Drug 20
6.3.5 Net Penetration of Drug 20
6.3.6 Net Annual Dosing 20
6.3.7 Annual Cost of Therapy 21
6.3.8 Primary Research 21
6.3.9 Expert Panels 21
6.4 Contact Us 21
6.5 Disclaimer 21
6.6 Sources 21

List of Table


Table 1: Gastric Cancer, Incidences and Mortality, 2008-2030 5
Table 2: Gastric Cancer, Global, Market Forecast ($bn), 20092020 7
Table 3: Drug Risk Benefit Score of Tesetaxel 15
Table 4: Gastric Cancer, Estimated Global Sales for Tesetaxel ($m), 20142020 18

List of Chart


Figure 1: Percentage Distribution of Top 20 Diagnosed Cancers 4
Figure 2: Fatality = [(%Distribution of Incidence) (% Distribution Mortality )] of Top 20 Cancers 5
Figure 3: Per Capita Cigarette Consumption , The US, 1976-2006 6
Figure 4: Gastric Cancer, Global, Market Size Forecast ($bn), 20092020 7
Figure 5: Oncology, Global, Incidence (in millions), 2008-2030 8
Figure 6: Gastric Cancer, Global, Incidence (in millions), 2008-2030 9
Figure 7: Broad Classification of Gastric Cancer in the US and EU-5 10
Figure 8: Broad Classification of Gastric Cancer in Japan 10
Figure 9: Detailed TNM Classification 11
Figure 10: Classification of Gastric Cancer in the US and EU-5 12
Figure 11: Classification of Gastric Cancer in Japan 12
Figure 12: Drug Model Diagram of Tesetaxel in the US, the UK and EU 16
Figure 13: Drug Model Diagram of Tesetaxel in Japan 17
Figure 14: Gastric Cancer, Estimated Global Sales for Tesetaxel ($m), 20142020 18
Figure 15: Gastric Cancer, Sales Forecast for Tesetaxel by Country ($m), 2020 19

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *